Oncology nurses made it a point to get to know Barbara Bigelow, a breast cancer survivor, while she was getting treatment. To her, that made a big difference.
Oncology nurses made it a point to get to know Barbara Bigelow, a breast cancer survivor, while she was getting treatment. To her, that made a big difference.
Transcription
Chemo nurses, they have to deal wit so many issues in such a complete person, plus the person they've brought with them. Who knows who that person is that might have a million questions. I always had my daughter with me. The second go-around, and the first time I had my husband with me. But you never know what you're going to get.
They will just be so great. "Do you want some graham crackers? Do you want a heated blanket? Can I get you something?" Not that they're your waitress, but they care about you and would take the time to sit and talk to you and get to know you and remember you. That was huge to me.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.
FDA Grants Accelerated Approval to Fam-Trastuzumab Deruxtecan-Nxki in HER2+ Solid Tumors
April 5th 2024The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu) for patients with unresectable or metastatic HER2-positive solid tumors who have received prior systemic treatment.